search
Back to results

GraftJacket Versus Tendon Interposition for Trapeziometacarpal Osteoarthritis

Primary Purpose

Osteoarthrosis of the Carpometacarpal Joint of the Thumb

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
GraftJacket
Tendon Interposition
Sponsored by
Schulthess Klinik
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthrosis of the Carpometacarpal Joint of the Thumb

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion criteria:

  • All adult patients diagnosed for TMC OA
  • willing to participate and provide informed consent

Exclusion criteria:

  • Patients with rheumatoid arthritis,
  • pregnant women,
  • legal incompetent patients,
  • persons with insufficient knowledge of the German language to complete the questionnaires

Sites / Locations

  • Schulthess Klinik

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

GraftJacket

Tendon Interposition

Arm Description

GraftJAcket is used as interpositional material

Flexor carpi radialis tendon is used as interpositional material

Outcomes

Primary Outcome Measures

Pain subscale of the Michigan Hand Questionnaire, 1 year following surgery

Secondary Outcome Measures

Secondary objectives are the comparison of the complications associated with the different surgical procedures as well as a cost-utility analysis.

Full Information

First Posted
November 1, 2012
Last Updated
August 19, 2016
Sponsor
Schulthess Klinik
search

1. Study Identification

Unique Protocol Identification Number
NCT01724840
Brief Title
GraftJacket Versus Tendon Interposition for Trapeziometacarpal Osteoarthritis
Official Title
Resection Suspension Arthroplasty With Interposition of GraftJacket Versus Tendon Interposition for Trapeziometacarpal Osteoarthritis: A Randomised Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2016
Overall Recruitment Status
Completed
Study Start Date
September 2012 (undefined)
Primary Completion Date
April 2015 (Actual)
Study Completion Date
April 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Schulthess Klinik

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Studies at the shoulder, Achilles tendon and thumb show satisfactory results regarding the use of GaftJacket. Initial trials at the thumb show, that the GraftJacket can be safely and successfully used in TMC OA surgery and therefore represents an acceptable alternative for avoiding possible donor-site morbidity. However, there are no randomised controlled trials (RCT) in which the outcomes of using a tendon interposition or the GraftJacket are compared. Only with an RCT design it is possible to gain evidence about the advantages of one treatment method over another. The main objective of the study is the comparison between two surgical techniques for TMC OA: The resection interposition suspension arthroplasty using a part of the flexor carpi radialis tendon as interpositional material and using the GraftJacket as interpositional material.
Detailed Description
Besides the use of the flexor carpi radialis tendon, several materials can serve as the interposition tissue including Gore-Tex, silicone and other types of metal or polymer implants. The use of Gore-Tex, silicone and metal implants, have been shown to carry high complication rates secondary to synovitis and mechanical failure combined with poor patient outcomes. A study about a porcine collagen xenograft was terminated prematurely because of poor outcomes and adverse immunologic reactions. Another option is using allograft, which is dermal or tendon tissue from another human donor such as the GraftJacket (Wright Medical Technology, Inc., Arlington, TN). This product is manufactured from donated cadaveric tissue that is treated to remove all cellular components while preserving the native collagen scaffold. It thus provides the strength and integrity of native autograft without the adverse immunologic response of traditional allograft. It is in compliance with the American Association of Tissue Banks guidelines for allograft material, and it is classified as human tissue for transplantation. The GraftJacket shows high biocompatibility and the advantages compared to autograft are avoiding donor site morbidity as well as decreased surgical time. GraftJacket has mainly being used for the repair of rotator cuff tears and Achilles tendons ruptures. No complications have been reported and patients showed significant improved outcomes compared with their preoperative conditions. Although all of the studies show methodological limitations due to the lack of a control group, these results show a great potential and warrant further investigations. In contrast to the studies already conducted in the Achilles tendon and shoulder joint, there are only sparse data concerning other joints of the upper extremity such as the elbow and the hand. Treating TMC OA of Eaton stage ll, lll and lV with GraftJacket has only been reported in two studies. The patients under investigation reported significant pain relief, significant improvements regarding grip and key pinch strength, good ability to perform activities of daily living (ADL) and high satisfaction rates. No or only minimal postoperative complications such as paraesthesia which are not directly related to the GraftJacket have been reported. However, some limitations of these two studies have to be acknowledges. Both are observational studies without control group making it impossible to conclude if this approach is favourable compared to standard techniques.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthrosis of the Carpometacarpal Joint of the Thumb

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
GraftJacket
Arm Type
Experimental
Arm Description
GraftJAcket is used as interpositional material
Arm Title
Tendon Interposition
Arm Type
Active Comparator
Arm Description
Flexor carpi radialis tendon is used as interpositional material
Intervention Type
Procedure
Intervention Name(s)
GraftJacket
Intervention Description
Interposition with GraftJacket
Intervention Type
Procedure
Intervention Name(s)
Tendon Interposition
Intervention Description
Tendon Interposition with the FCR tendon
Primary Outcome Measure Information:
Title
Pain subscale of the Michigan Hand Questionnaire, 1 year following surgery
Time Frame
preOP, 6 weeks, 3, 6, and 12months post OP
Secondary Outcome Measure Information:
Title
Secondary objectives are the comparison of the complications associated with the different surgical procedures as well as a cost-utility analysis.
Time Frame
preOP, 6 weeks, 3, 6, and 12months post OP
Other Pre-specified Outcome Measures:
Title
Costs, Treatment satisfaction, objective and subjective function
Time Frame
preOP, 6 weeks, 3, 6, and 12months post OP

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria: All adult patients diagnosed for TMC OA willing to participate and provide informed consent Exclusion criteria: Patients with rheumatoid arthritis, pregnant women, legal incompetent patients, persons with insufficient knowledge of the German language to complete the questionnaires
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Daniel B Herren, MD, MHA
Organizational Affiliation
Schulthess Klinik
Official's Role
Principal Investigator
Facility Information:
Facility Name
Schulthess Klinik
City
Zurich
ZIP/Postal Code
8008
Country
Switzerland

12. IPD Sharing Statement

Learn more about this trial

GraftJacket Versus Tendon Interposition for Trapeziometacarpal Osteoarthritis

We'll reach out to this number within 24 hrs